[go: up one dir, main page]

TR200100316T2 - Yeni benz [f] indollerin üretim yöntemleri, ilaç olarak kullanımları - Google Patents

Yeni benz [f] indollerin üretim yöntemleri, ilaç olarak kullanımları

Info

Publication number
TR200100316T2
TR200100316T2 TR2001/00316T TR200100316T TR200100316T2 TR 200100316 T2 TR200100316 T2 TR 200100316T2 TR 2001/00316 T TR2001/00316 T TR 2001/00316T TR 200100316 T TR200100316 T TR 200100316T TR 200100316 T2 TR200100316 T2 TR 200100316T2
Authority
TR
Turkey
Prior art keywords
production methods
drugs
indoles
benz
new
Prior art date
Application number
TR2001/00316T
Other languages
English (en)
Inventor
Grauert Matthias
Hoenke Christoph
Carter Adrian
Bechtel Wolf-Dietrich
Weiser Thomas
Palluk Rainer
Pschorn Uwe
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of TR200100316T2 publication Critical patent/TR200100316T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Eldeki bulus, ikame edilmis 2,3,3a,4,9,9a-heksa-hidro-8-hidroksi-1H-benz[f] indol türevlerini, bunlarin üretim yöntemlerini ve tibbi ilaç olarak kullanimlarini konu almaktadir. Bulusa uygun indol türevleri, genel formül 1 ' e uygundurlar.
TR2001/00316T 1998-07-31 1999-07-22 Yeni benz [f] indollerin üretim yöntemleri, ilaç olarak kullanımları TR200100316T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19834714A DE19834714A1 (de) 1998-07-31 1998-07-31 Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
TR200100316T2 true TR200100316T2 (tr) 2001-07-23

Family

ID=7876092

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00316T TR200100316T2 (tr) 1998-07-31 1999-07-22 Yeni benz [f] indollerin üretim yöntemleri, ilaç olarak kullanımları

Country Status (29)

Country Link
US (1) US6051583A (tr)
EP (1) EP1100780B1 (tr)
JP (1) JP2002522418A (tr)
KR (1) KR20010072142A (tr)
CN (1) CN1147470C (tr)
AT (1) ATE360611T1 (tr)
AU (1) AU763834B2 (tr)
BG (1) BG105178A (tr)
BR (1) BR9912605A (tr)
CA (1) CA2336783C (tr)
CO (1) CO5080748A1 (tr)
DE (2) DE19834714A1 (tr)
EA (1) EA003370B1 (tr)
EE (1) EE200100062A (tr)
ES (1) ES2285851T3 (tr)
HU (1) HUP0103518A3 (tr)
ID (1) ID28292A (tr)
IL (1) IL140863A0 (tr)
MY (1) MY133085A (tr)
NO (1) NO20010513D0 (tr)
NZ (1) NZ510246A (tr)
PL (1) PL345808A1 (tr)
SK (1) SK1502001A3 (tr)
TR (1) TR200100316T2 (tr)
TW (1) TW464643B (tr)
UA (1) UA68388C2 (tr)
WO (1) WO2000007986A1 (tr)
YU (1) YU5501A (tr)
ZA (1) ZA200007770B (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002666D0 (en) 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels
AU2002364545A1 (en) * 2001-12-27 2003-07-24 Ortho-Mcneil Pharmaceutical Inc. Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE152708T1 (de) * 1989-07-13 1997-05-15 Upjohn Co (1,2n) und (3,2n)-karbozyklische-2-amino- tetralinderivate
WO1992021654A2 (en) * 1991-05-20 1992-12-10 The Upjohn Company Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives
GB9612153D0 (en) * 1996-06-11 1996-08-14 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
SK1502001A3 (en) 2001-09-11
EP1100780A1 (de) 2001-05-23
UA68388C2 (en) 2004-08-16
MY133085A (en) 2007-10-31
NO20010513L (no) 2001-01-30
HUP0103518A3 (en) 2002-12-28
CA2336783A1 (en) 2000-02-17
CN1147470C (zh) 2004-04-28
CO5080748A1 (es) 2001-09-25
DE19834714A1 (de) 2000-02-03
NO20010513D0 (no) 2001-01-30
HK1038017A1 (en) 2002-03-01
CA2336783C (en) 2009-04-28
KR20010072142A (ko) 2001-07-31
TW464643B (en) 2001-11-21
IL140863A0 (en) 2002-02-10
HUP0103518A2 (hu) 2002-01-28
YU5501A (sh) 2003-04-30
NZ510246A (en) 2003-08-29
ATE360611T1 (de) 2007-05-15
AU5162699A (en) 2000-02-28
ES2285851T3 (es) 2007-11-16
ZA200007770B (en) 2002-01-17
EA003370B1 (ru) 2003-04-24
PL345808A1 (en) 2002-01-02
EP1100780B1 (de) 2007-04-25
EE200100062A (et) 2002-06-17
ID28292A (id) 2001-05-10
AU763834B2 (en) 2003-07-31
JP2002522418A (ja) 2002-07-23
BG105178A (bg) 2001-12-29
CN1310707A (zh) 2001-08-29
US6051583A (en) 2000-04-18
BR9912605A (pt) 2001-05-02
EA200100107A1 (ru) 2001-08-27
WO2000007986A1 (de) 2000-02-17
DE59914314D1 (de) 2007-06-06

Similar Documents

Publication Publication Date Title
NO20015379L (no) Indolinderivater som progesteronantagonister
TR199802269T2 (tr) Endotelin reseptör antagonistleri olarak faydali indol türevleri.
MXPA05010174A (es) Derivados de indol e indolina sustituidos.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AR027059A1 (es) Bases de mannich indolicas, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su uso para la preparacion de medicamentos
TR199902590T2 (tr) Birlesik 5HT1A 5HT1B ve 5HT1D reseptör antagonist aktivitesi olan indol türevleri.
ATE275545T1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
DE10199016I1 (de) Indol derivate zur Behandlung von Migraene
TR200001452T2 (tr) Bifenilamidin türevleri.
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
ATE307133T1 (de) Hexahydroazepino(4,5-g)indole und -indoline als 5-ht-rezeptor-liganden
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
NO173869C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,7-kondenserte 1h-indol-2-carboxylsre-n-(1,4-benzodiazepin-3-yl)-amider
AP2001002149A0 (en) Indole derivatives(Priority title)
ATE254122T1 (de) Indolderivate als 5-ht1b und 5-ht1d agonisten
AU2001261707A1 (en) Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
TR200100316T2 (tr) Yeni benz [f] indollerin üretim yöntemleri, ilaç olarak kullanımları
TR200101808T2 (tr) Psikotik hastalıkların tedavisi için 3-tetrahidropiridin-4-il indoller
IT1317926B1 (it) Derivati triciclici dell'indolo ad attivita' antiangiogenica.
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
EA200600455A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600456A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200100056A1 (ru) Производные 4,5,6 и 7-замещенного индола и индолина, их получение и применение